跳至主要内容
临床试验/CTRI/2019/05/019119
CTRI/2019/05/019119尚未招募2 期

A PROSPECTIVE OPEN LABELLED, NON-RANDOMIZED, PHASE II CLINICAL TRIAL OF “ATTATHI CHOORANAM†IN THE MANAGEMENT OF “RAKTHA SOORAI VAAYU†(POLY CYSTIC OVARIAN SYNDROME)

Government Siddha Medical College and Hospital1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2019年5月14日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
Diagnosis of RAKTHA SOORAI VAAYU and evaluation of the therapeutic efficacy of Attathi chooranam. It is assessed by the improvement in the score of irregular menstruation (Intermenstrual period & duration of bleeding) before and after treatment.

研究概览

简要总结

The study is a prospective open labelled, non-randomised, phase II clinical trial to determine the efficacy and safety of ATTATHI CHOORANAM in patients with RAKTHA SOORAI VAAYU ( POLY CYSTIC OVARIAN SYNDROME). The trial drug is processed from raw herbs and mineral. In this clinical trial to be held at GSMC, Palayamkottai, 40 patients (20 in OPD + 20 in IPD) will be recruited and the trial drug will be administered at the dose of 40 mg/ Kg/ BW TDS A/F along with Honey or ghee as adjuvant for a period of 48 days. All the study related data will be recorded and documented in a separate file for each patients. In case of any adverse event (AE) is noticed and it will be referred to pharmacovigilance department of SCRI. Further management of patient will be given in OPD, GSMC, Palayamkottai. During this trial all the efficacy and safety parameters will be recorded in the CRF. After completion of trial all the study related data will be analysed statistically.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Open Label

入排标准

年龄范围
15.00 Year(s) 至 45.00 Year(s)(—)
性别
Female

入选标准

  • Marital Status : Married / Unmarried II.
  • Symptoms -Irregular menstruation, oligomenorrhoea (or) amenorrhoea (or) dysmenorrhoea (or) dysfunctional uterine bleeding -Hirsuitism and obesity III.
  • Patient willing to take USG pelvis IV.
  • Patient willing to undergo routine blood investigation V.
  • USG pelvis showing polycystic ovaries VI.
  • Patient willing to participate in trial and signing in consent form.

排除标准

  • History of recent hormone therapy (within one year) II.
  • Lactating mother.
  • History of renal disease V.
  • History of Liver diseas VI.
  • Uterine anomalies.

结局指标

主要结局

Diagnosis of RAKTHA SOORAI VAAYU and evaluation of the therapeutic efficacy of Attathi chooranam. It is assessed by the improvement in the score of irregular menstruation (Intermenstrual period & duration of bleeding) before and after treatment.

时间窗: 48 days

次要结局

  • Changes in the polycystic swellings of the ovaries in USG pelvis and reduction of other symptoms.(48 days)

研究者

发起方
Government Siddha Medical College and Hospital
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验